Nastech Pharmaceutical Company Inc. to Present at the Invest Northwest CEO & Investor Forum

Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) announced today that it will present at the Invest Northwest CEO & Investor Forum on Tuesday, March 18, 2008, at 4:30 p.m. Pacific Time at the Bell Harbor International Conference Center in Seattle, Washington.

To access the live audio webcast for this conference, please log on to Nastechs Web site at http://www.nastech.com approximately 15 minutes prior to the presentation in order to register and download any necessary software. A replay of the audio presentation will be available following the event.

About Nastech

Nastech is a clinical stage biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products based on its proprietary molecular biology-based drug delivery technologies and, through its wholly-owned subsidiary, MDRNA, Inc., based on its proprietary ribonucleic acid interference (RNAi) technology. Nastech and its collaboration partners are developing products for multiple therapeutic areas including osteoporosis, obesity, diabetes, autism, respiratory diseases and inflammatory conditions. Additional information about Nastech is available at http://www.nastech.com.

Contacts:

Nastech Pharmaceutical Company Inc.
Matthew D. Haines, 212-209-3874
Senior Director, Investor Relations and
Corporate Communications
ir@nastech.com
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here